teamNGS Balances Sensitivity for Viruses with Comprehensive Microbial Detection in Clinical Specimens
Authors:
- Julie YamaguchiJYJulie Yamaguchi
- Gregory S. OrfGOGregory S. Orf
- Jenna MalinauskasJMJenna Malinauskas
- Maximillian MataMMMaximillian Mata
- Sonja L. WeissSWSonja L. Weiss
- Kenn ForbergKFKenn Forberg
- Todd V. MeyerTMTodd V. Meyer
- Peter O. WiebePWPeter O. Wiebe
- Illya MowermanIMIllya Mowerman
- Stanley J. PiotrowskiSPStanley J. Piotrowski
- Daniel GlowniaDGDaniel Glownia
- Mary A. RodgersMRMary A. Rodgers
Open Access
- 16 December 2025
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 13 (12) , 2854
Abstract
Probe-based capture represents a highly sensitive and cost-effective approach for overcoming host background and enriching viruses in metagenomic NGS (mNGS) libraries. Using clinical specimens collected globally from patients with fever or respiratory illness, we generated mNGS libraries by random priming and Nextera XT tagmentation, followed by target enrichment (teNGS) with Comprehensive Viral Research Panel (CVRP) probes. Capture pool sizes and total reads were optimized, and libraries were initially sequenced separately. Using only 3–4% of reads required for standard mNGS, teNGS achieved increased sensitivity, 100–10,000× increases in depth, and >50% genome coverage for pathogens with titers ≥ 1000 cp/mL. Application to >2000 clinical specimens from various matrices and to contrived samples containing viruses absent from the CVRP probe set enabled detection of diverse viral families and established a minimum 65% nucleotide identity for hybridization, respectively. To save time and resources, teNGS and mNGS libraries were then combined into one sequencing run: teamNGS. In addition to streamlining the workflow, teamNGS also improved genome recovery. Coupling methods maintain the sensitivity and coverage for viruses achieved by enrichment alone while also ensuring comprehensive recovery of non-viral microbes. teamNGS has the potential to improve patient management and lower the rates of unnecessary testing and antibiotic use.Keywords
Funding Information
- Abbott Laboratories
This publication has 55 references indexed in Scilit:
- Robust mission-driven responses to infectious disease threats delivered by the Abbott pandemic defense coalitionInternational Journal of Infectious Diseases, 2025
- The Regulatory Landscape for Clinical Metagenomic TestingJAMA Neurology, 2025
- Targeted whole-viral genome sequencing from formalin-fixed paraffin-embedded neuropathology specimensActa Neuropathologica, 2024
- Application of VirCapSeq-VERT and BacCapSeq in the diagnosis of presumed and definitive neuroinfectious diseasesJournal of NeuroVirology, 2023
- Phylodynamic and genetic diversity of parvoviruses of cats in southern IndiaVirusDisease, 2022
- The Abbott Pandemic Defense Coalition: a unique multisector approach adds to global pandemic preparedness effortsInternational Journal of Infectious Diseases, 2022
- Benchmark of thirteen bioinformatic pipelines for metagenomic virus diagnostics using datasets from clinical samplesJournal of Clinical Virology, 2021
- Redondoviridae, a Family of Small, Circular DNA Viruses of the Human Oro-Respiratory Tract Associated with Periodontitis and Critical IllnessCell Host & Microbe, 2019
- Inhibition mechanisms of hemoglobin, immunoglobulin G, and whole blood in digital and real-time PCRAnalytical and Bioanalytical Chemistry, 2018
- HHV-6 reactivation as a cause of fever in autologous hematopoietic stem cell transplant recipientsJournal of Infection, 2017